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Calcium channelopathies. Calcium is an important intracellular Fig. 1). The extracellular loops that connect the S5 and
signaling molecule, and altered calcium channel function can S6 segments of each repeat contribute to the formation
cause widespread cellular changes. Genetic mutations in cal-
of the ion-conducting pore, and the S4 segments (whichcium channels that cause what appear to be trivial alterations
contain basic residues at every third position) are respon-of calcium currents in vitro can result in serious diseases in
muscles and the nervous system. This article reviews calcium sible for “sensing” the changes of membrane potential
channelopathies in humans and mice. that cause the channel to “gate” between closed, open
and inactivated states. In addition to carrying out the
principle channel functions of gating and permeation, the
Mutations of genes encoding calcium channels are rap-
a1 subunit contains the binding sites for calcium channelidly being identified as causing a diverse group of nerve
agonists and antagonists.and muscle diseases. These mutations have been identi-
Currently, 10 calcium channel a1 subunits have beenfied in humans, mice and other organisms. In this review,
cloned and sequenced: a1A, a1B, a1C, a1D [1], a1E [2], a1Fwe will summarize calcium channelopathies of humans
[3, 4], a1G [5], a1H [6], a1I [7], and a1S [8]. Many of theseand mice. For basic scientists interested in calcium chan-
a1 subunits have been associated with specific types ofnels, the existence of disease-causing mutations raises
calcium currents, which were first described on the basisthe hope that their investigations will ultimately have
of pharmacological and biophysical criteria. Of thoseclinical significance. Additionally, the disease-causing
discussed in this review, a1C and a1S correspond to L-typemutations may provide new insight into the cell biologi-
calcium channels, originally defined on the basis of phar-cal roles of calcium channels as well as into relationships
between structure and function. However, the calcium macological sensitivity to dihydropyridines. Because of
channelopathies differ from those of voltage-gated so- the tissues in which they are highly expressed, a1C and
dium and potassium channels, in which altered electrical a1S are often referred to as cardiac and skeletal muscle
excitability of nerve and muscle can be clearly under- isoforms, respectively. Based on its amino acid sequence,
stood in terms of altered biophysical properties of the a1F is also an L-type channel, which is highly expressed
channels. Since calcium is an important intracellular sig- in retina [3, 4]. The a1A channel is expressed in cell bodies,
naling molecule, altered calcium channel function can dendrites and presynaptic terminals of most central neu-
give rise to widespread changes in cellular function. In- rons [9] with highest expression in cerebellar neurons
deed, serious diseases result from mutations that cause [9–13] and produces current kinetically and pharmaco-
trivial alterations of calcium currents analyzed in vitro. logically (sensitive to v-Aga-IVA) defined as P/Q-type
Thus, clearly we have much to learn about the biological
[14]. The a1B channel is primarily expressed in dendritesroles of calcium channels.
and nerve terminals [15] with a wide distribution
throughout the brain [16] and is blocked by v-CTX-
STRUCTURE AND FUNCTION OF VOLTAGE- GVIA [17], a defining characteristic of N-type current.
GATED CALCIUM CHANNELS In addition to the a1 subunit, most calcium channels
All voltage-gated calcium channels contain an a1 sub- contain the auxiliary subunits a2-d, which is proposed to
unit and most have associated auxiliary subunits. The a1 have a single membrane-spanning segment, and b, which
subunit has four homologous repeats (I to IV), each of is entirely cytoplasmic. Some channels (a1S) have been
which has six membrane-spanning segments (S1 to S6; shown to contain a g subunit, which is thought to have
four membrane-spanning segments. The auxiliary sub-
units modify channel expression, voltage-dependenceKey words: calcium channel, gene mutation, cellular function, voltage-
gated Ca channels, muscle, neuron. and kinetics, with the most pronounced effects arising
from the b subunit [reviewed in 18].Ó 2000 by the International Society of Nephrology
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Fig. 1. Schematic membrane topology of the a1F calcium channel subunit with mutations causing incomplete X-linked congenital stationary night
blindness. Both the amino and carboxyl terminals are intracellular; Roman numerals indicate the four homologous repeats, each of which contains
six putative transmembrane segments (designated S1 to S6). In this and all subsequent figures, mutations are indicated by the number of the
affected amino acid. X represents conversion to a stop codon and # represents a frameshift/premature stop resulting from a single base insertion
or deletion.
CALCIUM CHANNELOPATHIES OF THE Mutations in a1A
NERVOUS SYSTEM Mutations in the a1A calcium channel subunit have
been shown to produce the human autosomal-dominantNeuronal calcium channels have many cellular func-
neurological disorders of familial hemiplegic migraine,tions including: control of neurotransmitter release, reg-
episodic ataxia type-2, spinocerebellar ataxia-6, and epi-ulation of gene expression, integration and propagation
sodic-and-progressive ataxia. Defects in the gene encod-of postsynaptic signals, and neurite outgrowth. In addi-
ing the a1A calcium channel subunit are also responsibletion to altering these signaling pathways, calcium channel
for the recessively inherited phenotypes of tottering (tg)mutations could in principle cause cytotoxicity. In partic-
and leaner (tgla) in mice. In each of these diseases, alter-ular, both increased [reviewed in 19] and decreased [20–
ation of a single gene results in a host of neurological22] intracellular Ca21 have been reported to be cytotoxic
aberrations including abnormal cerebellar function andto neurons.
cerebellar atrophy. In general, a1A mutations have pro-
nounced effects on the cerebellum, which is not surpris-Mutations of a1F
ing given that a1A is highly expressed in cerebellar neu-Incomplete X-linked congenital stationary night blind-
rons. In particular, about 90% of rat Purkinje cell calcium
ness. Human incomplete X-linked congenital stationary
current is blocked with high affinity by the toxin v-Aga-
night blindness (incomplete xlCSNB) is a heterogeneous, IVA [24], indicating that this large fraction of current
nonprogressive disorder with impairment of night vision arises from a1A [14].and variably reduced day vision, which is thought to Familial hemiplegic migraine. Familial hemiplegic mi-
result from altered synaptic transmission from photo- graine (FHM) is associated with headaches accompanied
receptor cells to second-order neurons. Incomplete by aura and hemiparesis (which is typically transient
xlCSNB has been linked to mutations in the a1F subunit lasting hours to days), ataxia and nystagmus. In some
of a retinal L-type channel. These mutations include families, cerebellar atrophy may also occur. The onset
missense, deletions, and frameshifts with premature stops of this disorder is usually in childhood or adolescence.
(Fig. 1) [3, 4]. The effects of these mutations on channel Genetic studies of FHM patients have identified four
function have not yet been characterized. However, since missense mutations causing defects in the a1A subunit:
synaptic transmission from photoreceptor cells to sec- R192Q, T666M, V714A, and I1811L [25]. These mis-
ond-order retinal neurons is mediated by L-type current sense mutations affect highly conserved residues [26] and
[23], it seems likely that a1F is at least partially responsible are widely distributed throughout the protein (Fig. 2).
for this transmission and that the a1F mutations may The effects of these four FHM mutations on calcium
currents have been studied by two groups. The first groupimpair transmission.
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Fig. 2. Mutations of the a1A calcium channel subunit causing human (open symbols) and murine (closed symbols) neurological disorders. Three
mutations cause episodic ataxia-2: a base deletion in codon 1266 causes a premature stop at amino acid 1294, a single nucleotide change in codon
1279 causes a premature stop, and an intronic mutation alters sequence beginning at amino acid 1332. In spinocerebellar ataxia 6, the polyglutamine
expansion begins at amino acid 2328. The leaner mutation is a single nucleotide substitution in a splice donor consensus sequence causing altered
sequence beginning at amino acid 1922 or 1968.
[27] introduced the mutations into the cDNA encoding cence. Three mutations causing EA-2 have been identi-
fied in a1A (Fig. 2). The first is a single nucleotide deletionan isoform (BI-2) of rabbit a1A and coexpressed it in
Xenopus oocytes with the a2-d and b1a subunits. The that causes a frameshift within IIIS1 and translational
stop shortly thereafter [25], the second is a single basesecond group [28] introduced the mutations into human
a1A-2 and coexpressed it in HEK293 cells with a2b-d and mutation that introduces a premature stop into IIIS1-
S2 linker [29], and the third alters an intronic 59 spliceeither b2e or b3a. Both groups found that: (1) R192Q
produced little in the way of biophysical alterations; (2) junction causing translational stop within IIIS2 [25]. One
might expect that with such mutations there would beT666M slowed recovery from inactivation; and (3)
V714A and I1819L both accelerated recovery from inac- little or no mutant protein (effectively genetic nulls),
which seemingly contradicts dominant inheritance unlesstivation. Additionally, Hans et al found that: (1) channel
density in HEK293 cells was increased for R192Q and there is haploinsufficiency. Alternatively, the prema-
turely truncated protein could be a dominant negativedecreased for the other three mutants; (2) that channel
open probability was increased for R192Q, V714A and if it acted as a molecular sink for cytoplasmic proteins
important for calcium channel localization and function.I1819L; and (3) single channel conductance was de-
creased for T666M and V714A [28]. Thus, some of these Autosomal dominant spinocerebellar ataxia 6. Au-
tosomal dominant spinocerebellar ataxia 6 (SCA6) ismutations would be expected to increase calcium entry
and some would be expected to decrease it. Obviously, dominantly inherited. It is characterized by ataxia, nys-
tagmus, dysarthria, and neuronal loss in the cerebellumit is difficult to explain why this diverse set of changes
in channel properties all produce the FHM phenotype. (Purkinje and granule cells) and the dentate and inferior
olivary nuclei. Symptoms initially appear at 40 to 50Episodic ataxia-2. Episodic ataxia-2 (EA-2) is associ-
ated with ataxia, nystagmus, dysarthria and vertigo. Cer- years of age and become progressively more severe.
Analyses of patients with SCA6 demonstrated the pres-ebellar atrophy is common, and 50% of EA-2 patients
report migraine-like symptoms. The ataxia is provoked ence of an expanded CAG repeat (normal individuals
having 4 to16 CAGs and affected individuals having 21 toby stress, exercise or fatigue and lasts hours to days.
Onset of this disorder is usually late childhood or adoles- 27 CAGs), which is much smaller than the trinucleotide
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repeats associated with other neurodegenerative disor- sequence that begins at amino acid 1968 and terminates
90 amino acids later [36, 37].ders [30]. Similar CAG expansions have been observed
In Purkinje cells from tgla mice, whole cell calciumin individuals having symptoms of both SCA6 and EA-2
current is reduced in amplitude ,65% [38, 41, 42]. The[31] or only of EA-2 [32], which may indicate that the two
reduction is specifically in the v-Aga-IVA-sensitive com-diseases actually represent a continuum of symptoms.
ponent of current, and the remaining v-Aga-IVA-sensi-The CAG expansion in SCA6 introduces polygluta-
tive current has unchanged gating properties [42]. Dove,mines at a position approximately 100 amino acids from
Abbott and Griffith suggest that the reduced currentthe carboxyl terminal (Fig. 2). Increased repeat size is
density results from decreased open probability [41]. In-associated with both greater disease severity and earlier
terestingly, Wakamori et al found that the behavior ofonset. The pathological consequences of many diseases
short and long tgla isoforms differed [38]. In comparisoninvolving trinucleotide repeats are thought to be related
with wild-type a1A expressed in BHK cells, the currentto altered stability of the mutant protein, toxic metabolic
density was unchanged for the long isoform althoughbreakdown products of the glutamines, or the interaction
both activation and inactivation were shifted in the depo-of the CAG repeats with proteins required for processing
larizing direction (5 to 10 mV), whereas current densityRNA. Alternatively, the polyglutamine expansion caus-
was reduced for the short isoform without any othering SCA6 might alter the biophysical properties, expres-
changes. As is the case for FHM, the relationship be-sion or protein–protein interactions of a1A. tween altered channel properties and neuropathologyEpisodic and progressive ataxia. Episodic and pro-
remains unclear.gressive ataxia has some clinical attributes which overlap
with SCA6 and EA-2. Distinguishing features include Mutations in auxiliary subunits of calcium channels
earlier onset (5 to 15 years of age), more prominent Lethargic. A recessive mouse disorder, lethargic (lh)
cerebellar atrophy and, unlike EA-2, insensitivity to includes behavioral traits overlapping those of human
treatment with acetazolamide. The disease has been as- and murine a1A diseases (ataxia and absence seizuressociated with a missense mutation (G293R; Fig. 2) of a [43]), but without apparent neuroneal degeneration [44].
conserved amino acid in the S5-S6 linker (pore region) The causative mutation is an insertion of four nucleotides
of repeat I of a1A [33]. into a splice donor site of the gene encoding the b4
Tottering. As a recessively inherited neurological dis- auxiliary subunit [45]. This results in two mutant isoforms
ease of mice, tottering (tg) is characterized by seizures of b4, both of which are lacking the consensus sequence
(absence and focal motor) and mild ataxia [34]. There required for binding to a1 subunits (Fig. 3). McEnery et
is minor diffuse loss of cerebellar granule and Purkinje al found that the forebrain and cerebellum of lh mice
cells, an increased density of noradrenergic fibers from lack immunodetectable b4, have increased expression of
the locus coeruleus, and abnormal persistence of tyrosine b1B, and have decreased binding of v-CTX-GVIA, which
hydroxylase expression in Purkinje cells [35]. Tottering is a blocker of a1B-containing (N-type) calcium channels
results from a single nucleotide change that substitutes [46]. Studied by heterologous expression, an absence of
leucine for proline (P601L; Fig. 2) in the IIS5-S6 linker b leads to a profound decrease in the trafficking of chan-
of a1A [36, 37]. In BHK cells heterologously expressing nels to the plasmalemma as well as a significant effect on
the voltage-dependence and kinetics of channel gatingthe tg mutated channel, gating is unchanged but current
[reviewed in 18].density is reduced by 56%; calcium channel currents are
Stargazer. The stargazer (stg) is another recessive mu-also reduced in cerebellar Purkinje cells of tg mice [38].
rine disorder and is characterized by ataxia, head-tossingThe amplitude of single channel currents in the BHK
and absence seizures [47]. The disrupted gene encodescells is normal [38]. The reduction in current density may
stargazin, which is structurally similar to the g subunitbe a consequence of reduced channel open probability
of the skeletal muscle calcium channel (Fig. 3). Com-since cerebellar a1A mRNA is normal [37].
pared to expression of a1A alone, coexpression of a1A withLeaner. The leaner (tgla) is another recessively inher-
stargazin in BHK cells resulted in a small hyperpolarizingited disorder of mice that is characterized by severe
shift in inactivation without affecting peak current den-ataxia [34] and substantial loss of cerebellar Purkinje and
sity [48]. Removal of the effect of stargazin, as expectedgranule cells [39]. The surviving Purkinje cells exhibit
in the stargazer mutant, would increase the availabilityaberrant morphology [40]. The tgla mutation has been
of channels at resting membrane potential and thus pro-identified as a single nucleotide substitution in a splice
duce an increase in calcium influx.
donor consensus sequence of the a1A gene, which results
either in a short or long isoform. The short isoform has
CALCIUM CHANNELOPATHIES OF MUSCLEaltered sequence that begins at amino acid 1922 (Fig. 2;
numbered according to the mouse a1A) and terminates Calcium channel defects have been linked to several
human muscle disorders such as: hypokalemic periodic57 amino acids later, and the long isoform has altered
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Fig. 3. Topology of a neuroneal a1 subunit together with the b and g auxiliary subunits that are affected in murine neurological disorders. The
b subunit interacts with the I-II linker of the a1 subunit. The site of possible interaction between the a1 and g subunits is currently not known.
The lethargic mutation causes loss of the a1 binding site in b4. Stargazer has been associated with mutation of a putative neuronal g subunit.
paralysis (HypoPP), malignant hyperthermia (MH) and voking factors include emotion, stress, cold exposure
and alcohol ingestion. HypoPP has been associated withcentral core disease (CCD). Causative mutations have
been localized to the calcium channels involved in excita- three missense mutations in the voltage-sensing (S4) seg-
ments of a1S (Fig. 4): R528H located in IIS4 [50], andtion-contraction (E-C) coupling.
In skeletal muscle, electrical excitation of the plas- R1239H/G in IVS4 [51, 52].
A small number of studies has been carried out onmalemma causes the release of calcium stored intracellu-
larly within the sarcoplasmic reticulum (SR), which in cultured myotubes derived from muscle biopsies of
HypoPP patients carrying the R528H mutation. Oneturn activates the contractile proteins. Two key proteins
in this process of E-C coupling are the dihydropyridine study (based on three patients) found a small hyperpolar-
izing shift (,6 mV) in the voltage-dependence of bothreceptor (DHPR) in the plasmalemma and the ryano-
dine receptor (RyR) in the SR, which interact with one activation and inactivation of the L-type calcium current
(that is, the calcium current attributable to the a1S), butanother at specialized junctions between the plas-
malemma and SR. The DHPR is a voltage-gated calcium found no differences in depolarization-induced release
of calcium from the SR [53]. A second study (based onchannel containing the a1S subunit, and the RyR is a
calcium release channel composed of four identical sub- a single patient) found that the L-type current had a
slightly reduced density and greatly (twofold) slowedunits. A depolarization-induced conformational change
of the DHPR [8, 49] activates the RyRs. This activation activation [54].
Analyses by means of heterologous expression havemay involve a protein–protein interaction since E-C cou-
pling in skeletal muscle does not require the entry of not revealed any consistent functional changes in L-type
calcium channels with introduced HypoPP mutations.extracellular calcium. The DHPR also functions as a
conventional, voltage-gated calcium channel, but the Compared to wild-type a1S, expression in L-cells of
R528H rabbit a1S produced current with a 70% decreasefunction of the DHPR-mediated calcium current in skel-
etal muscle is not understood. in density but no significant differences in gating [55].
Compared to wild-type a1C, expression in HEK293 cellsHypokalemic periodic paralysis. Hypokalemic peri-
odic paralysis (HypoPP) is a dominantly inherited disor- of R650H a1C (homologous to R528H in a1S) produced
current with a 38% reduction in amplitude and a slightder presenting as episodic weakness of the trunk and
limbs, generally without myotonia, which can last hours (5 mV) hyperpolarizing shift of both activation and inac-
tivation [56]. In a preliminary report, Gonzales, Nakaito days. This weakness is accompanied by a reduction in
serum K1 levels. This disease usually becomes apparent and Beam described no significant differences in voltage-
dependence or kinetics of either L-type current or cal-during childhood or early adulthood and has reduced
penetrance in females. Attacks can be provoked by rest cium release in dysgenic myotubes after heterologous
expression of rabbit a1S containing the R528H, R1239Hafter exercise and factors that lower serum K1 levels
(carbohydrate ingestion or insulin injection); other pro- or R1239G mutations [57]. (Dysgenic myotubes are ob-
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Fig. 4. Schematic topologies of the a1S calcium channel subunit in the plasmalemma and the calcium release channel (RyR1) in the sarcoplasmic
reticulum of skeletal muscle. Mutations in the a1S subunit cause hypokalemic periodic paralysis and malignant hyperthermia (location of mutations
indicated on schematic). Mutations in RyR1 cause malignant hyperthermia alone or malignant hyperthermia and central core disease. The topology
of the RyR is not known, so the schematic locations of the mutations are not noted in the diagram.
tained from mice that lack a functional a1S gene). Simi- ders that arise from altered handling of intracellular cal-
cium [reviewed in 59, 60]. Thus, it is most convenientlarly, Jurkat-Rott et al found no differences in calcium
currents or calcium release between wild-type and when discussing these diseases to combine the informa-
tion about etiology and symptomatology. A number ofR528H rabbit a1S expressed in immortalized dysgenic
muscle cells [53]. mutations of the RyR have been shown to be responsible
for these diseases, but mutations of other proteins mayEven if heterologous expression had demonstrated
consistent effects on calcium currents or E-C coupling, also produce the disease (see below). No matter what
the causative mutation, RyRs represent an importantit would be difficult to explain the etiology of HypoPP.
Specifically, when bathed in low K1 solution, biopsied trigger point for the pathophysiology, since RyRs play
a key role in controlling intracellular calcium. In additionintercostal muscle fibers of HypoPP patients are depolar-
ized by 20 mV (compared to a 10 mV hyperpolarization to being regulated via the DHPR, RyRs are activated
by elevations in intracellular calcium (“calcium-induced-in normal muscle [58]). If a similar depolarization were
to occur in vivo, it would inactivate voltage-gated sodium calcium-release” or “CICR”). This CICR is “overactive”
in RyRs bearing MH or CCD mutations so that massivechannels and thus induce muscle paralysis. However,
there does not seem to be an obvious mechanism calcium release can be triggered by halogenated anesthe-
tics (which decrease the threshold for CICR) or by depo-whereby altered calcium currents or E-C coupling would
produce a persistent depolarization triggered by low K1. larizing skeletal muscle relaxants (which trigger low
amounts of calcium release via the normal E-C couplingPerhaps a very subtle change in DHPR function alters
intracellular calcium signaling pathways that regulate the pathway). An episode of MH can thus be triggered by
the pharmacological agents used during surgery. Theseexpression or function of muscle potassium channels.
Malignant hyperthermia (MH) and central core dis- episodes are characterized by skeletal muscle rigidity,
accelerated metabolism, rapid rise in body temperature,ease. Malignant hyperthermia (MH) and central core
disease (CCD) are dominantly inherited muscle disor- and tachycardia. Unless rapidly recognized and treated,
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these symptoms can progress quickly to fatality. Individ- In leaner and tottering mice, the a1A mutations cause
decreases in calcium current density and much less pro-uals with CCD are not only susceptible to MH, but also
display nonprogressive myopathy (usually presenting in nounced functional changes. In FHM, similar pheno-
types appear to result from functional alterations thatinfancy) associated with hypotonia and proximal muscle
weakness. Muscle biopsies from CCD patients are char- would increase calcium influx in some cases and decrease
it in others. HypoPP results from mutations in a1S, butacterized by amorphous central cores devoid of mito-
chondria. A chronically elevated myoplasmic calcium there is no current consensus that the mutations alter
the function of a1S or understanding how malfunction ofconcentration may be responsible for these pathological
changes. a1S could cause periodic paralysis. Malignant hyperther-
mia results from mutations of the RyR, which is an intra-Thus far, 17 identified missense mutations in RyR1
(the RyR isoform expressed in skeletal muscle) have cellular calcium release channel. The MH mutations not
only have significant effects on intracellular calcium re-been associated with MH susceptibility (Fig. 4) [60].
While some mutations produce MH alone, other muta- lease, but also provide a rational basis for understanding
the etiology of this condition.tions cause both MH and CCD. An MH-related porcine
disorder [reviewed in 59] is caused by the mutation As a general rule, mutations causing drastic changes in
calcium channel function are most likely not compatibleR615C in the porcine RyR1, which is homologous to
the R614C mutation in humans. Swine homozygous for with life. Furthermore, because calcium is such an impor-
tant signaling molecule, even small changes in calciumR615C suffer “porcine stress syndrome” with MH symp-
toms brought on by physical and emotional stress (over- channels may dramatically alter cellular development
and homeostasis. A relatively large number of mutationsheating, exercise, mating, transport to market and fear).
Mutations in genes other than RyR1 may be also be have been associated with a1A. Possibly this is because
defects, which are not so serious as to be fatal, nonethe-responsible for MH. For example, in a single family, MH
segregated with a missense mutation (R1086H; Fig. 4) less sufficiently alter function of the cerebellum to cause
easily detected locomotor defects. Perhaps linkage anal-in the a1S gene [61]. Moreover, the demonstration of
ysis will eventually establish connections between muta-linkages between MH and several loci distinct from ei-
tions of other neuroneal a1 subunits and more subtlether RyR1 or a1S indicate the possibility of additional
disorders of neurological function.gene targets for MH [60].
Muscle biopsies, cultured myotubes and heterologous
expression have all been used to analyze the functional
ACKNOWLEDGMENTconsequences of RyR1 mutations that cause MH. Muscle
bundles biopsied from MH patients contract in response This work was supported by NIH grant NS24444 to K.G.B.
to lower concentrations of caffeine and halothane (a
Reprint requests to Dr. Kurt G. Beam, Department of Anatomy &halogenated anesthetic) than muscle from normal indi-
Neurobiology, Colorado State University, Fort Collins, Colorado,
viduals. An enhanced sensitivity of intracellular calcium 80523, USA.
E-mail: kbeam@lamar.colostate.edurelease to halothane was also observed in cultured myo-
tubes derived from MH patients [62]. Calcium release
from SR vesicles of MH muscle exhibited a lower thresh-
REFERENCESold for activation by calcium, an enhanced sensitivity to
1. Snutch TP, Leonard JP, Gilbert MM, Lester HA, Davidson N:caffeine, and a reduced sensitivity to inhibitory concen-
Rat brain expresses a heterogeneous family of calcium channels.trations of calcium [63]. Finally, heterologous expression
Proc Natl Acad Sci USA 87:3391–3395, 1990
in HEK293 cells of most of the MH mutations in RyR1 2. Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR, Snutch
TP: Structure and functional expression of a member of the lowcaused an increased sensitivity to low concentrations of
voltage-activated calcium channel family. Science 260:1133–1136,caffeine and halothane [64]. There have been no reports
1993
on the functional consequences of the R1086H mutation 3. Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop
B, Fishman GA, Mets M, Musarella MA, Boycott KM: Loss-in a1S.
of-function mutations in a calcium-channel a1-subunit gene in
Xp11.23 cause incomplete X-linked stationary night blindness. Nat
Genet 19:264–267, 1998CONCLUSION
4. Strom TM, Nyakatura G, Apefelstedt-Sylla E, Hellebrand H,
Lorenz B, Weber BHF, Wutz K, Gutwillinger N, Ruther K,In summary, mutations in a1F alter retinal function, but
Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A,currently little is known about the properties of channels
Meindl A: A l-type calcium-channel gene mutated in incomplete
containing a1F. These a1F mutations may impair synaptic X-linked congenital stationary night blindness. Nature Genet
19:260–263, 1998transmission in the retina because they lead to the loss
5. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J,or under-expression of a1F channels. Altered cerebellar Williamson MP, Fox M, Rees M, Lee J-H: Molecular characteriza-
function has been associated with a number of mutations tion of a neuronal low voltage-activated T-type calcium channel.
Nature 391:896–900, 1998in a1A, which is highly expressed in cerebellar neurons.
Lorenzon and Beam: Calcium channelopathies 801
6. Cribbs LL, Lee J-H, Yang J, Satin J, Zhang Y, Daud A, Barclay DE, Ferrari M, Hann J, Lindhout D, van Ommen G-JB, Hofker
MH, Ferrari MD, Frants RR: Familial hemiplegic migraine andJ, Williamson MP, Fox M, Rees M, Perez-Reyes E: Cloning and
characterization of a1H from human heart, a member of the T-type episodic ataxia type-2 are caused by mutations in the Ca21 channel
gene CACNL1A4. Cell 87:543–552, 1996calcium channel gene family. Circ Res 83:103–109, 1998
7. Lee J-H, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, 26. Fujita Y, Mynlieff M, Dirksen RT, Kim M-S, Niidome T, Nakai
J, Friedrich T, Iwabe N, Miyata T, Furuichi T, Furutama D,Klockner U, Schneider T, Perez-Reyes E: Cloning and expres-
sion of a novel member of the low voltage-activated T-type calcium Mikoshiba K, Mori Y, Beam KG: Primary structure and functional
expression of the v-conotoxin-sensitive N-type calcium channelchannel family. J Neurosci 19:1912–1921, 1999
8. Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, from rabbit brain. Neuron 10:585–598, 1993
27. Kraus RL, Sinnegger MJ, Glossmann H, Hering S, StressnigKangawa K, Kojima M, Matsuo H, Hirose T, Numa S: Primary
structure of the receptor for calcium channel blockers from skeletal J: Familial hemiplegic migraine mutations change a1A Ca21 channel
kinetics. J Biol Chem 273:5586–5590, 1998muscle. Nature 328:313–318, 1987
9. Westenbroek RE, Sakurai T, Elliott EM, Hell JW, Starr TVB, 28. Hans M, Luvisetto S, Williams ME, Spagnolo M, Urrutia A,
Tottene A, Brust PF, Johnson EC, Harpold MM, StaudermanSnutch TP, Catterall WA: Immunochemical identification and
subcellular distribution of the a1A subunits of brain calcium chan- KA, Pietrobon D: Functional consequences of mutations in the
human a1A calcium channel subunit linked to familial hemiplegicnels. J Neurosci 15:6403–6418, 1995
10. Mori Y, Friedrich T, Kim M-S, Mikami A, Nakai J, Ruth P, Bosse migraine. J Neurosci 19:1610–1619, 1999
29. Yue Q, Jen JC, Thwe MM, Nelson SF, Baloh RW: De novoE, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto
K, Tanabe T, Numa S: Primary structure and functional expression mutation in CACNA1A caused acetazolamide-responsive episodic
ataxia. Am J Med Genet 77:298–301, 1998from complementary DNA of a brain calcium channel. Nature
350:398–402, 1991 30. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW,
Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC: Au-11. Sather WA, Tanabe T, Zhang J-F, Mori Y, Adams ME, Tsien
RW: Distinctive biophysical and pharmacological properties of tosomal dominant cerebellar ataxia (SCA6) associated with small
polyglutamine expansions in the a1A-voltage-dependent calciumClass A (B1) calcium channel a1 subunits. Neuron 11:291–303,
1993 channel. Nat Genet 15:62–69, 1997
31. Geschwind DH, Perlman S, Figueroa KP, Karrim J, Baloh RW,12. Starr TVB, Prystay W, Snutch TP: Primary structure of a calcium
channel that is highly expressed in the rat cerebellum. Proc Natl Pulst SM: Spinocerebellar ataxia type 6: Frequency of the muta-
tion and genotype-phenotype correlations. Neurology 49:1247–Acad Sci USA 88:5621–5625, 1991
13. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vin- 1251, 1997
32. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G,cent SR, Snutch TP: Localization and functional properties of a
rat brain a1A calcium channel reflect similarities to neuronal Q- Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F,
Ophoff RA, Frants RR, Frontali M: Episodic ataxia type 2and P-type channels. Proc Natl Acad Sci USA 91:10576–10580,
1994 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG
repeat expansion in the CACNA1A gene on chromosome 19p.14. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E,
Monteil A, Zamponi GW, Nargeot J, Snutch TP: Splicing of the Hum Molec Genet 6:1973–1978, 1997
33. Yue Q, Jen JC, Nelson SF, Baloh RW: Progressive ataxia duea1A subunit gene generates phenotypic variants of P- and Q-type
calcium channels. Nature Neurosci 2:407–415, 1999 to a missense mutation in a calcium-channel gene. Am J Hum
Genet 61:1078–1087, 199715. Westenbroek RE, Hell JW, Warner C, Dubel SJ, Snutch TP,
Catterall WA: Biochemical properties and subcellular distribu- 34. Noebels JL: A single gene error of noradrenergic axon growth
synchronizes central neurones. Nature 310:409–411, 1984tion of an N-type calcium channel a1 subunit. Neuron 9:1099–1115,
1992 35. Hess EJ, Wilson MC: Tottering and leaner mutations perturb
transient developmental expression of tyrosine hydroxylase in em-16. Dubel SJ, Starr TNB, Hell J, Ahlijanian MK, Enyeart JJ,
Catterall WA, Snutch TP: Molecular cloning of the a-1 subunit bryologically distinct Purkinje cells. Neuron 6:123–132, 1991
36. Fletcher CF, Lutz CM, O’Sullivan TN, Shaughnessy JD Jr,of an v-conotoxin-sensitive calcium channel. Proc Natl Acad Sci
USA 89:5058–5062, 1989 Hawkes R, Frankel WN, Copeland NG, Jenkins N: Absence
epilepsy in tottering mutant mice is associated with calcium channel17. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S,
Maroufi A, McCue AF, Velicelebi G, Ellis SB, Harpold MM: defects. Cell 87:607–617, 1996
37. Doyle J, Ren X, Lennon G, Stubbs L: Mutations in the Cacnl1a4Structure and functional expression of an v-conotoxin-sensitive
human N-type calcium channel. Science 257:389–395, 1992 calcium channel gene are associated with seizures, cerebellar de-
generation, and ataxia in tottering and leaner mutant mice. Mamm18. Walker D, De Waard M: Subunit interaction sites in voltage-
dependent Ca21 channels: Role in channel function. Trends Neu- Genome 8:113–120, 1997
38. Wakamori M, Yamazaki K, Matsunodaira H, Teramoto T, Ta-rosci 21:148–154, 1993
19. Choi DW: Calcium-mediated neurotoxicity: Relationship to spe- naka I, Niidome T, Sawada K, Nishizawa Y, Sekiguchi N, Mori
E, Mori Y, Imoto K: Single tottering mutations responsible forcific channel types and role in ischemic damage. Trends Neurosci
11:465–469, 1988 the neuropathic phenotype of the P-type calcium channel. J Biol
Chem 273:34857–34867, 199820. Koh JY, Cotman CW: Programmed cell death: Its possible contri-
bution to neurotoxicity mediated by calcium channel antagonists. 39. Herrup K, Wilczynski SL: Cerebellar cell degeneration in the
leaner mutant mouse. Neuroscience 7:2185–2196, 1982Brain Res 587:233–240, 1992
21. Koike T, Martin DP, Johnson EM Jr: Role of Ca21 channels in 40. Heckroth JA, Abbott LC: Purkinje cell loss from alternating
sagittal zones in the cerebellum of leaner mutant mice. Brain Resthe ability of membrane depolarization to prevent neuronal death
induced by trophic-factor deprivation: Evidence that levels of inter- 658:93–104, 1994
41. Dove LS, Abbott LC, Griffith WH: Whole-cell and single-channelnal Ca21 determine nerve growth factor dependence of sympathetic
ganglion cells. Proc Natl Acad Sci USA 86:6421–6425, 1989 analysis of P-type calcium currents in cerebellar Purkinje cells of
leaner mutant mice. J Neurosci 18:7687–7699, 199822. McCaslin PP, Smith TG: Low calcium-induced release of gluta-
mate results in autotoxicity of cerebellar granule cells. Brain Res 42. Lorenzon NM, Lutz CM, Frankel MN, Beam KG: Altered cal-
cium channel currents in Purkinje cells of the neurological mutant53:280–285, 1990
23. Schmitz Y, Witzovsky P: Dependence of photoreceptor glutamate mouse leaner. J Neurosci 18:4482–4489, 1998
43. Sidman RL, Green MC, Appel SH: Catalog of Neurological Mu-release on a dihydropyridine-sensitive calcium channel. Neurosci-
ence 78:1209–1216, 1997 tants of the Mouse. Cambridge, The Harvard University Press, 1965
44. Dung HC, Swigart RH: Histo-pathologic observations of the ner-24. Mintz IM, Adams ME, Bean BP: P-type calcium channels in rat
central and peripheral neurons. Neuron 9:85–95, 1992 vous and lymphoid tissues of the ‘lethargic’ mutant mouse. Tex
Rep Biol Med 30:23–39, 197225. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner
PJ, Hoffman SMG, Lamberdin JE, Mohrenweiser HW, Bulman 45. Burgess DL, Jones JM, Meisler MH, Noebels JL: Mutation of
Lorenzon and Beam: Calcium channelopathies802
the Ca21 channel b subunit gene Cchb4 is associated with ataxia 55. Lapie P, Goudet C, Nargeot J, Fontaine B, Lory P: Electrophysi-
ological properties of the hypokalemic periodic paralysis mutationand seizures in the lethargic (lh) mouse. Cell 88:385–392, 1997
(R528H) of the skeletal muscle a1S subunit as expressed in mouse46. McEnery MW, Copeland TD, Vance CL: Altered expression and
L cells. FEBS Lett 382:244–248, 1996assembly of N-type calcium channel a1B and b subunits in epileptic
56. Lerche H, Klugbauer N, Lehmann-Horn F, Hofmann F, Melzerlethargic (lh/lh) mouse. J Biol Chem 273:21435–21438, 1998
W: Expression and functional characterization of the cardiac l-type47. Noebels JL, Qiao X, Bronson RT, Spencer C, Davisson MT:
calcium channel carrying a skeletal muscle DHP-receptor mutationStargazer: A new neurological mutant on Chromosome 15 in the
causing hypokalemic periodic paralysis. Pflu¨gers Arch 431:461–463,mouse with prolonged cortical seizures. Epilepsy Res 7:129–135,
19961990
57. Gonzalez A, Nakai J, Beam K: IVS4 mutations which alter inacti-48. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL,
vation of the skeletal l-type calcium channel without affectingValenzuela A, Bartlett FSII, Mori Y, Campbell KP, Frankel
activation. Biophys J 70:A128, 1996WN: The mouse stargazer gene encodes a neuronal Ca21 channel
58. Rudel R, Lehmann-Horn F, Ricker K, Kuther G: Hypokalemicg subunit. Nat Genet 19:340–347, 1998
periodic paralysis: In vitro investigation of muscle fiber membrane49. Rios E, Brum G: Involvement of dihydropyridine receptors in
parameters. Muscle Nerve 7:110–120, 1984excitation-contraction coupling in skeletal muscle. Nature 325:717–
59. Mickelson JR, Louis CF: Malignant hyperthermia: Excitation-720, 1987
contraction coupling, Ca21 release channel, and cell Ca21 regulation50. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, Heine R, Gregg
defects. Physiol Rev 76:537–592, 1996RG, Hogan K, Powers P, Lapie P, Vale-Santos JE: A calcium
60. Loke J, MacLennan DH: Malignant hyperthermia and centralchannel mutation causing hypokalemic periodic paralysis. Hum
core disease: Disorders of Ca21 release channels. Am J MedMol Genet 56:374–380, 1994
104:470–486, 199851. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwie-
61. Monnier N, Procaccio V, Stieglitz P, Lunardi J: Malignant-cinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradley hyperthermia susceptibility is associated with a mutation of theP, Leppert MF: Dihydropyridine receptor mutations cause hypoka-
a1-subunit of the human dihydropyridine-sensitive l-type voltage-lemic periodic paralysis. Cell 77:863–868, 1994 dependent calcium-channel receptor in skeletal muscle. Am J Hum
52. Fouad G, Dalakas M, Servidei S, Mendell JR, Van den Bergh Genet 60:1316–1325, 1997
P, Angelini C, Alderson K, Griggs RC, Tawil R, Gregg R, 62. Censier K, Urwyler A, Zorzato F, Treves S: Intracellular cal-
Hogan K, Powers PA, Weinberg N, Malonee W, Ptacek LJ: cium homeostasis in human primary muscle cells from malignant
Genotype-phenotype correlations of DHP receptor a1-subunit hyperthermia-susceptible and normal individuals. J Clin Invest
gene mutations causing hypokalemic periodic paralysis. Neuromus- 101:1233–1242, 1998
cul Disord 7:33–38, 1997 63. Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, Herr-
53. Jurkat-Rott K, Uetz U, Pika-Hartlaub U, Powell J, Fontaine mann-Frank A: Functional characterization of a distinct ryanodine
B, Melzer W, Lehmann-Horn F: Calcium currents and transients receptor mutation in human malignant hyperthermia-susceptible
of native and heterologously expressed mutant skeletal muscle muscle. J Biol Chem 272:5256–5260, 1997
DHP receptor a1 subunits (R528H). FEBS Lett 423:198–204, 1998 64. Tong J, Oyamada H, Demaurex N, Grinstein S, McCarthy TV,
54. Morrill JA, Brown RH Jr, Cannon SC: Gating of the l-type Ca MacLennan DH: Caffeine and halothane sensitivity of intracellu-
channel in human skeletal myotubes: An activation defect caused lar Ca21 release is altered by 15 calcium release channel (ryanodine
by the hypokalemic periodic paralysis mutation R528H. J Neurosci receptor) mutations associated with malignant hyperthermia and/
or central core disease. J Biol Chem 272:26332–26339, 199718:10320–10334, 1998
